| 4-HNE | 4-hydroxy-2,3-nonenal |
| ABVD | Adriamycin, Bleomycin, Vincristine and Dexamethasone |
| ACR | Acrolein |
| AGEs | Advanced glycation end-products |
| ALEs | Advanced lipid peroxidation end-products |
| ALL | Acute lymphoblastic leukemia |
| AML | Acute myeloid leukemia |
| AOPPs | Advanced oxidation protein products |
| APL | Acute promyelocytic leukemia |
| B CLL | B-cell chronic lymphoblastic leukemia |
| BM | Bone marrow |
| CAT | Catalase |
| CHOP | Cyclophosphamide, Vincristine, Doxorubicin, and Prednisone |
| CML | Chronic myeloid leukemia |
| COX | Cyclooxygenase |
| DFX | Deferasirox |
| DLBCL | Diffuse large B-cell lymphoma |
| DNP | Dinitrophenylhydrazone |
| DNPH | Dinitrophenylhydrazine |
| DOX-TRF | Doxorubicin-transferrin |
| ET | Essential thrombocythemia |
| GO | Glyoxal |
| GPX | Glutathione peroxidase |
| HL | Hodgkin lymphoma |
| IOL | Iron overload |
| LO | Lipoxygenase |
| MAD | Malondialdehyde |
| MGO | Methyglyoxal |
| MGUS | Monoclonal gammapathy of undetermined significance |
| MM | Multiple myeloma |
| MPN | Myeloproliferative neoplasms |
| NANA | N-acetyl neuraminic acid |
| NHL | Non-Hodgkin lymphoma |
| NOS | Nitric oxide synthase |
| ns | Nonsignificant |
| ONE | 4-oxo-2-nonenal |
| PC | Protein carbonylation |
| PMF | Primary myelofibrosis |
| PN | Protein nitrosylated |
| PUFA | Polyunsaturated fatty acyl |
| PV | Polycythemia vera |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| TBARS | Thiobarbituric reactive substances |
| Trx | Thioredoxin |
| VAD | Vincristine–Adriamycin–Dexamethasone |